25. Berild D, Smaabrekke L, Halvorsen DS, Lelek M, Stahlsberg EM, Ringcrtz SH. Clostridium difficile infections related to antibiotic use and infection control facilities in two university hospitals./ Hosp Infect 2003;54:202-6.
26. Surawicz CM, McFarland LV, Greenberg RN, Rubin M, Fekety R, Mulligan ME, et al. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 2000;31:1012-7.
27. Hummer S, Weaver MA, Harris JC, Dee P, Hunter J. Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C difficile diarrhoea. Int Microbiol 2004;7:59-62.
28. Berrington A, Borriello SP, Brazier J, Duckworth G, Foster K, Freeman R, et al. National Clostridium difficile Standards Group: report to the Department of Health./ Hosp Infect 2004;56(Suppl l):l-38.
29. Johal SS, Lambert CP, Hammond J, James PD, Borriello SP, Mahida YR. Colonic IgA producing cells and macrophages are reduced in recurrent and non-recurrent Clostridium difficile associated diarrhoea./ Clin Pathol 2004;57:973-9.
30. Wilcox MH. Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea./ 2004;53:882-4.
31. Starr JM, Campbell A. Mathematical modelling of Clostridium difficile infection. Clin Microbiol Infect 2001;7:432-7.